Saturday, January 30, 2021

Mid month Market Report

 


End of January  Pricing Update and Forecast

Each month about this time we look back at the previous month, analyze how pricing has behaved and report on how well our forecasting techniques performed. We also give a forecast for how pricing will move over the next month.

For the monthly period ending January 15, we are currently recording a sales $/SF of $214.92 averaged for all areas and types across the ARMLS database. This is up 3.0% from the $208.70 we now measure for December 15. Our forecast range mid-point was $212.50, with a 90% confidence range of $208.25 to $216.75. Prices rebounded sharply from the brief lull in early December and came in $2.42 higher than we forecast. However the actual result was well within the 90% confidence interval.

On January 15 the pending listings for all areas & types show an average list $/SF of $218.10, up 2.2% from the reading for December 15. Among those pending listings we have 98.8% normal, 0.5% in REOs and 0.7% in short sales and pre-foreclosures. There has been little change in these percentages compared with last month, and the number of distressed sales remains extremely low by historic standards.

Our mid-point forecast for the average monthly sales $/SF on February 15 is $220.18, which is 2.4% above the January 15 reading. We have a 90% confidence that it will fall within ± 2% of this mid point, i.e. in the range $215.78 to $224.58.

Average sale $/SF has risen 15.8% in the last 6 months, equivalent to an annual appreciation rate of over 31%. If our forecast proves accurate the next month will take us to an 18.6% increase over 7 months.

Appreciation rates of over 20% are inevitable by the time we get to April 2021.

From Cromford Report-The data used to create the Cromford® Report is obtained from public records and obtained under license from the Arizona Regional Multiple Listing Service, Inc (ARMLS). Cromford Associates LLC and ARMLS expressly disclaim and make no representations or warranties of any kind, whether express, implied or statutory, as to the accuracy of the data used.